Skip to main content
Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
323.69
+3.03 (0.94%)
Nov 20, 2024, 4:00 PM EST - Market closed

Bio-Rad Laboratories Revenue

Bio-Rad Laboratories had revenue of $649.73M in the quarter ending September 30, 2024, with 2.79% growth. This brings the company's revenue in the last twelve months to $2.58B, down -5.15% year-over-year. In the year 2023, Bio-Rad Laboratories had annual revenue of $2.67B, down -4.67%.

Revenue (ttm)
$2.58B
Revenue Growth
-5.15%
P/S Ratio
3.56
Revenue / Employee
$321,321
Employees
8,030
Market Cap
9.06B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.67B-130.99M-4.67%
Dec 31, 20222.80B-120.30M-4.12%
Dec 31, 20212.92B376.92M14.81%
Dec 31, 20202.55B233.97M10.12%
Dec 31, 20192.31B22.24M0.97%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Henry Schein 12.50B
Teleflex 3.03B
Bio-Rad Laboratories 2.58B
Masimo 2.04B
Qiagen 1.97B
Penumbra 1.16B
HealthEquity 1.10B
Tempus AI 640.44M
Revenue Rankings

BIO News

More News